Have a feature idea you'd love to see implemented?
Let us know!
VANI Vivani Medical Inc
Price (delayed)
$1.33
Market cap
$78.78M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.44
Enterprise value
$77.48M
Second Sight Medical Products, Inc. (NASDAQ: EYES) develops, manufactures and markets implantable visual prosthetics that are intended to deliver useful artificial vision to blind individuals. A recognized global leader in
Highlights
The EPS is up by 21% year-on-year and by 4.3% since the previous quarter
Vivani Medical's net income has increased by 13% YoY and by 3.1% QoQ
The equity has contracted by 30% YoY and by 23% from the previous quarter
The company's quick ratio fell by 26% QoQ and by 4.8% YoY
Key stats
What are the main financial stats of VANI
Market
Valuations
Earnings
Shares outstanding
59.23M
Market cap
$78.78M
Enterprise value
$77.48M
Price to earnings (P/E)
N/A
Price to book (P/B)
4.01
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
EBIT
-$23.46M
EBITDA
-$22.76M
Free cash flow
-$19.46M
Per share
Balance sheet
Liquidity
EPS
-$0.44
Free cash flow per share
-$0.35
Book value per share
$0.33
Revenue per share
$0
TBVPS
$0.78
Total assets
$42.9M
Total liabilities
$24.56M
Debt
$19.68M
Equity
$18.33M
Working capital
$15.13M
Debt to equity
1.07
Current ratio
3.41
Quick ratio
3.35
Net debt/EBITDA
0.06
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-49.2%
Return on equity
-102.4%
Return on invested capital
-63.7%
Return on capital employed
-64.1%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
VANI stock price
How has the Vivani Medical stock price performed over time
Intraday
3.1%
1 week
-7.64%
1 month
3.1%
1 year
40%
YTD
30.39%
QTD
13.68%
Financial performance
How have Vivani Medical's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$24.43M
Net income
-$23.46M
Gross margin
N/A
Net margin
N/A
VANI's operating income is up by 14% YoY and by 3.3% QoQ
Vivani Medical's net income has increased by 13% YoY and by 3.1% QoQ
Growth
What is Vivani Medical's growth rate over time
Valuation
What is Vivani Medical stock price valuation
P/E
N/A
P/B
4.01
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS is up by 21% year-on-year and by 4.3% since the previous quarter
VANI's price to book (P/B) is 40% less than its 5-year quarterly average of 6.7 but 29% more than its last 4 quarters average of 3.1
The equity has contracted by 30% YoY and by 23% from the previous quarter
Efficiency
How efficient is Vivani Medical business performance
Vivani Medical's return on invested capital has surged by 53% YoY
The return on equity has declined by 34% year-on-year and by 5% since the previous quarter
The return on assets has increased by 4.7% year-on-year but it has declined by 2.3% since the previous quarter
Dividends
What is VANI's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for VANI.
Financial health
How did Vivani Medical financials performed over time
The total assets is 75% more than the total liabilities
The company's quick ratio fell by 26% QoQ and by 4.8% YoY
Vivani Medical's current ratio has decreased by 25% QoQ and by 17% YoY
The debt is 7% higher than the equity
VANI's debt to equity is up by 34% year-on-year and by 27% since the previous quarter
The equity has contracted by 30% YoY and by 23% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.